Inspire Medical Systems Inc. is facing ongoing litigation after disclosing in August 2025 that the launch of its Inspire V device would be delayed due to undisclosed issues. The company revealed that many centers had not completed necessary training, contracting, and onboarding, and that required software updates for claims processing were not implemented until July. Additionally, excess inventory led to poor demand for the device. Following these revelations, the company significantly reduced its 2025 earnings guidance by more than 80 percent. Subsequently, a securities class action lawsuit was filed, alleging that the company and certain executives failed to disclose material information in violation of federal securities laws. An investigation has also been initiated to determine whether Inspire Medical’s officers or directors breached their fiduciary duties or violated state or federal laws.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Inspire Medical Systems Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202602132222PR_NEWS_USPR_____DA88189) on February 14, 2026, and is solely responsible for the information contained therein.